T7 peptide-functionalized nanoparticles utilizing RNA interference for glioma dual targeting

International Journal of Pharmaceutics

Volumn 454, Issue 1, 2013, Pages 11-20

  Kuang, Yuyang ^a   An, Sai ^a   Guo, Yubo ^a   Huang, Shixian ^a   Shao, Kun ^a   Liu, Yang ^a   Li, Jianfeng ^a   Ma, Haojun ^a   Jiang, Chen ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Dendrigraft poly L lysines; Glioma dual targeting; RNA interference; T7 peptide; Transferrin

Indexed keywords

DENDRIMER; LUCIFERASE; MACROGOL; NANOPARTICLE; PEPTIDE DERIVATIVE; POLYLYSINE; SMALL INTERFERING RNA; T7 PEPTIDE; TRANSFERRIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTOMA CELL; BLOOD BRAIN BARRIER; BRAIN CAPILLARY ENDOTHELIAL CELL; BRAIN TUMOR; CANCER GENE THERAPY; CELL VIABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENDOCYTOSIS; GENE SILENCING; GLIOMA; HIPPOCAMPUS; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NANOMEDICINE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; PUTAMEN; QUANTITATIVE ANALYSIS; RNA INTERFERENCE; SUBSTANTIA NIGRA; ZETA POTENTIAL;

EID: 84884162825     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.07.019     Document Type: Article

References (27)

1. Abdolhamid Angaji, S., Hedayati, S.S., Poor, R.H., Madani, S., Poor, S.S., Panahi, S., 2010. Application of RNA interference in treating human diseases. J. Genet. 89, 527-537.
2. Davidson, B.L., McCray, P.B., 2011. Current prospects for RNA interference-based therapies. Na. Rev. Genet. 12, 329-340.
3. Douglas, K.L., Piccirillo, C.A., Tabrizian, M., 2008. Cell line-dependent internalization pathways and intracellular trafficking determine transfection efficiency of nanoparticle vectors. Eur. J. Pharm. Biopharm. 68, 676-687. (Pubitemid 351318216)
4. Fidler, I.J., Yano, S., Zhang, R., Fujimaki, T., Bucana, C.D., 2002. The seed and soil hypothesis: vascularisation and brain metastases. Lancet Oncol. 3, 53-57. (Pubitemid 34121146)
5. Wohlfart, S., Gelperina, S., Kreuter, J., 2012. Transport of drugs across the blood-brain barrier by nanoparticles. J. Control. Release 161, 264-273.
6. Liu, S., Guo, Y., Huang, R., Li, J., Huang, S., Kuang, Y., Han, L., Jiang, C., 2012. Gene and doxorubicin co-delivery system for targeting therapy of glioma. Biomaterials 33, 4907-4916.
7. Fortin, D., 2012. The blood-brain barrier: its influence in the treatment of brain tumors metastases. Curr. Cancer Drug Targets 12, 247.
8. Gaumet, M., Vargas, A., Gurny, R., Delie, F., 2008. Nanoparticles for drug delivery: the need for precision in reporting particle size parameters. Eur. J. Pharm. Biopharm. 69, 1-9. (Pubitemid 351467152)
9. Grzelinski, M., Urban-Klein, B., Martens, T., Lamszus, K., Bakowsky, U., Höbel, S., Czubayko, F., Aigner, A., 2006. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts. Hum. Gene Ther. 17, 751-766. (Pubitemid 44100720)
10. Huang, R., Liu, S., Shao, K., Han, L., Ke, W., Liu, Y., Li, J., Huang, S., Jiang, C., 2010. Evaluation and mechanism studies of PEGylated dendrigraft poly-L-lysines as novel gene delivery vectors. Nanotechnology 21, 265101.
11. Ji, B., Maeda, J., Higuchi, M., Inoue, K., Akita, H., Harashima, H., Suhara, T., 2006. Pharmacokinetics and brain uptake of lactoferrin in rats. Life Sci. 78, 851-855. (Pubitemid 43082309)
12. Khatri, N., Rathi, M., Baradia, D., Trehan, S., Misra, A., 2012. In vivo delivery aspects of miRNA, shRNA and siRNA. Crit. Rev. Ther. Drug 29, 487.
13. Kim, D.H., Rossi, J.J., 2007. Strategies for silencing human disease using RNA interference. Nat. Rev. Genet. 8, 173-184.
14. Kortmann, R.D., Jeremic, B., Weller, M., Plasswilm, L., Bamberg, M., 2003. Radiochemotherapy of malignant glioma in adults. Strahlenther. Onk. 179, 219-232.
15. Lee, J.H., Engler, J.A., Collawn, J.F., Moore, B.A., 2001. Receptor mediated uptake of peptides that bind the human transferrin receptor. Eur. J. Biochem. 268, 2004-2012. (Pubitemid 32852941)
16. Li, G., Wang, R., Gao, J., Deng, K., Wei, J., Wei, Y., 2011. RNA interference-mediated silencing of iASPP induces cell proliferation inhibition and G0/G1 cell cycle arrest in U251 human glioblastoma cells. Mol. Cell. Biochem. 350, 193-200.
17. Lo, R.C., Joffe, A.M., 2012. Influence of DNA-dye complex stability on separation resolution in microchip electrophoresis. Bioanalysis 4, 693-701.
18. Lu, P.Y., Xie, F., Woodle, M.C., 2005. In vivo application of RNA interference: from functional genomics to therapeutics. Adv. Genet. 54, 117.
19. Oh, S., Kim, B.J., Singh, N.P., Lai, H., Sasaki, T., 2009. Synthesis and anti-cancer activity of covalent conjugates of artemisinin and a transferrin-receptor targeting peptide. Cancer Lett. 274, 33-39.
20. Pang, Z., Gao, H., Yu, Y., Chen, J., Guo, L., Ren, J., Wen, Z., Su, J., Jiang, X., 2011. Brain delivery and cellular internalization mechanisms for transferrin conjugated biodegradable polymersomes. Int. J. Pharm. 415, 284-292.
21. Sanai, N., Alvarez-Buylla, A., Berger, M.S., 2005. Neural stem cells and the origin of gliomas. N. Engl. J. Med. 353, 811-822.
22. Scaggiante, B., Dapas, B., Farra, R., Grassi, M., Pozzato, G., Giansante, C., Grassi, G., 2011. Improving siRNA bio-distribution and minimizing side effects. Curr. Drug Metab. 12, 11.
23. Scaringi, C., Minniti, G., Caporello, P., Enrici, R.M., 2012. Integrin inhibitor cilengitide for the treatment of glioblastoma: a brief overview of current clinical results. Anticancer Res. 32, 4213-4223.
24. Stupp, R., Mason, W.P., Van Den Bent, M.J., Weller, M., Fisher, B., Taphoorn, M.J.B., Belanger, K., Brandes, A.A., Marosi, C., Bogdahn, U., 2005. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352, 987-996. (Pubitemid 40349501)
25. Ulbrich, K., Hekmatara, T., Herbert, E., Kreuter, J., 2009. Transferrin-and transferr-inreceptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB). Eur. J. Pharm. Biopharm. 71, 251-256.
26. Wang, B., Han, L., Chen, R., Cai, M., Han, F., Lei, T., Guo, D.S., 2009. Down-regulation of LRIG2 expression by RNA interference inhibits glioblastoma cell (GL15) growth, causes cell cycle redistribution, increases cell apoptosis and enhances cell adhesion and invasion in vitro. Cancer Biol. Ther. 8, 1018-1023.
27. Zhang, P., Hu, L., Yin, Q., Zhang, Z., Feng, L., Li, Y., 2012. Transferrin-conjugated polyphosphoester hybrid micelle loading paclitaxel for brain-targeting delivery: synthesis, preparation and in vivo evaluation. J. Control. Release 159, 429-434